Cargando…
p53 mutations in urinary bladder cancer
We have screened for mutations in exons 5–8 of the p53 gene in a series consisting of 189 patients with urinary bladder neoplasms. 82 (44%) neoplasms were lowly malignant (Ta, G1–G2a) and 106 (56%) were highly malignant (G2b–G4 or ≥T1). Only one mutation was in a lowly malignant urinary bladder neop...
Autores principales: | Berggren, P, Steineck, G, Adolfsson, J, Hansson, J, Jansson, O, Larsson, P, Sandstedt, B, Wijkström, H, Hemminki, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363660/ https://www.ncbi.nlm.nih.gov/pubmed/11384101 http://dx.doi.org/10.1054/bjoc.2001.1823 |
Ejemplares similares
-
Low interleukin-1α messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma
por: Seddighzadeh, M, et al.
Publicado: (2001) -
G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder
por: Niehans, G A, et al.
Publicado: (1999) -
p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer
por: Phillips, H A, et al.
Publicado: (2000) -
Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001) -
Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
por: Zienolddiny, S, et al.
Publicado: (2001)